Pathogenetic mechanisms related to EoE include alterations in barrier function with dysregulated filaggrin expression, 41 altered oesophageal motility and oesophageal stricture formation/long segment narrowing.
Mechanisms proposed as underlying these effects include alterations of protective antioxidant support, increased generation of harmful free radicals, and altered expression of apoptosis-related proteins.
The exemptions include alterations to air bags, seats, signaling systems, steering wheels, brake pedals and head rests.
Large mutations, which include alterations to chromosome structure and number, are relatively rare because most cause such major disruptions to development that the fetus is naturally aborted.
Physical processes potentially involved include alterations of the flow velocities, flow patterns, or of accessible surface sites.
Working capital restructuring does not include alterations of production processes, included in operational restructuring, to ensure conceptual rigor.
Other modifications of the ZSM-5 catalyst include alterations of the acidic properties using transition metals [1].
These changes include alterations in the histo-architecture of the mammary gland, prostate, testis, ovaries, adipose tissue, and brain.
DHEA-mediated cell surface changes include alterations in: cell surface charge, surface hydrophobicity, capsule production, and carotenoid production.
Potential mechanisms include alterations to the pain-modulating dopaminergic system and carbergoline, an ergot derivative, also possesses significant affinity for certain subtypes of serotonergic and adrenergic receptors.
A plausible proposed mechanism to explain the association between migraine and HT include alterations in the immune system, predisposing to thyroid autoimmunity.
